Cognitive Function News and Research

RSS

Cognition is a concept used in different ways by different disciplines, but is generally accepted to mean the process of thought. For example, in psychology and cognitive science it refers to an information processing view of an individual's psychological functions.

Researchers to begin drug development projects for rare and neglected diseases

Researchers will begin drug development projects for rare and neglected diseases that include potential treatments for a musculoskeletal disorder, a cognitive dysfunction disorder, a virus that affects the central nervous system of newborns, a parasitic worm infection, a form of muscular dystrophy and a rare lung disease.

16 Nov 2011

Exercise may help fibromyalgia: Study

A new study shows that fibromyalgia patients who stopped taking medication but exercised regularly for six weeks reported improved memory function and less pain. While the finding is encouraging, it does not suggest a potential change in clinical care for fibromyalgia patients, the study authors stressed.

15 Nov 2011

New human research shows benefits and challenges for aging brain

New human research released today shows the benefits and challenges for the aging brain. The studies probe common characteristics of normal aging - including memory loss, reduced sleep quality, and decision-making problems - and suggest the benefits of exercise, hormone treatment, and social interaction.

15 Nov 2011

New Chair of Forensic Mental Health at the University of New South Wales

Associate Professor Kimberlie Dean has been appointed the inaugural Chair of Forensic Mental Health at the University of New South Wales.

14 Nov 2011

Yissum Research and other investors complete additional investment round of $3 million in Avraham Pharmaceuticals

Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, today announced that it has participated in a U.S. $3 million financing round of Avraham Pharmaceuticals Ltd. together with Pontifax, Clal Biotechnology Industries (CBI), Technion Research and Development Foundation Ltd. (TRDF), Professor Marta Weinstock-Rosin and others.

14 Nov 2011

Top-line results from Probiodrug's PQ912 Phase 1 SAD, MAD study for Alzheimer's disease

Probiodrug AG, a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases, with a particular focus on Alzheimer's disease (AD), today announced top-line results of its Phase 1 single (SAD) and multiple ascending dose (MAD) study of PQ912 in healthy volunteers.

14 Nov 2011

Study uses fMRI to assess changes in brain after exercise intervention

Areas of the brain responsible for pain processing and cognitive performance changed in fibromyalgia patients who exercised following a medication holiday, say researchers from Georgetown University Medical Center. They say the changes indicate brain functioning is more streamlined after an exercise intervention because less of the brain-s resources is devoted to processing bothersome fibromyalgia perceptions such as pain.

14 Nov 2011

Conference highlights advances in evidence-based integrative therapies for cancer

Today the Society for Integrative Oncology highlighted top research findings presented at the Eighth International Conference this week in Cleveland, Ohio. More than 80 abstracts will be presented at the annual meeting, which will be keynoted by National Institutes of Health Director, Francis Collins, MD, PhD.

11 Nov 2011

Kessler Foundation neuropsychologists receive National Multiple Sclerosis Society grants

Two neuropsychologists at Kessler Foundation Research Center were awarded more than $100,000 in grants by the National Multiple Sclerosis Society. Nancy Chiaravalloti, PhD, received $63,000 to conduct a pilot study, "Speed of Processing Training for Improving Processing Speed in Persons with MS".

8 Nov 2011

Researchers discover biomarker for earlier diagnosis of MS

Researchers from the Department of Neurology at NYU Langone Medical Center identified for the first time that changes in the tissue located at the junction between the outer and inner layers of the brain, called "blurring", may be an important, non-invasive biomarker for earlier diagnosis and the development of new therapies for degenerative brain conditions, such as multiple sclerosis.

1 Nov 2011

GPS enabled shoes for “wandering seniors”

Now there are shoes with integrated GPS devices to help track down dementia-suffering seniors who wander off and get lost. This comes from manufacturer GTX Corp. Other devices such as bracelets or pendants can provide similar protection but seniors often reject these.

30 Oct 2011

Short sleep duration linked to weight gain in teens

Sleeping less than 8 hours a night may be linked to weight gain in teens, shows a new study presented at CHEST 2011, the 77th annual meeting of the American College of Chest Physicians.

24 Oct 2011

Common link between Type 2 diabetes and autism

A review of the genetic and biochemical abnormalities associated with autism reveals a possible link between the widely diagnosed neurological disorder and Type 2 diabetes, another medical disorder on the rise in recent decades.

20 Oct 2011

Autism in low birth weight babies five times more common: Study

Roughly 3% of U.S. newborns fall into the low-weight category used by the researchers (2,000 grams or less). Babies of this size are typically born prematurely, though certain pregnancy complications can also cause low birth weight in full-term babies.

18 Oct 2011

Accera identifies genetic profile of AD patients with heightened response to Axona

Accera, Inc., a biotech company specializing in cognitive health, announced today that it has identified the genetic profile of Alzheimer’s disease (AD) patients who have a high probability of responding to Axona (AC-1202), a prescription medical food product available at pharmacies nationwide.

18 Oct 2011

Obese post-menopausal women outperform normal weight counterparts in cognitive tasks

Obesity has been associated with cognitive decline, characterized by a deterioration of mental abilities that involve memory, language, and thought-processing speed.

14 Oct 2011

RAZCER (Rapid Astrazeneca and CARO Evaluation of Radio-modifiers) awards announced - five Canadians win

Five leading Canadian radiation oncologists receive RAZCER Awards of $22,727 each for novel studies of radiation-drug interactions that have the potential to either protect normal tissues or sensitize tumours, and thus to enhance the effectiveness of radiation therapy for cancer patients. A selection committee of members of the Canadian Association of Radiation Oncology (CARO) selected the 2011 recipients from among a field of 12 applicants. Astrazeneca provides the funds for the RAZCER Award as an educational grant.

13 Oct 2011

Shield commences two ST10 Phase 3 studies in iron deficiency anaemia

Shield Therapeutics (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need, today announced that the first patients have been treated in the two Phase 3 clinical studies of ST10 for the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease.

12 Oct 2011

Measurable changes in brain function may be a consequence of early HIV infection

Measurable changes in brain function and communication between brain regions may be a consequence of virus-induced injury during the early stages of human immunodeficiency virus (HIV) infection.

7 Oct 2011

NICU stress linked with alterations in brain structure and function of preterm infants

New research shows that exposure to stressors in the Neonatal Intensive Care Unit (NICU) is associated with alterations in the brain structure and function of very preterm infants. According to the study now available in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association and Child Neurology Society, infants who experienced early exposure to stress displayed decreased brain size, functional connectivity, and abnormal motor behavior.

4 Oct 2011

Cognitive Function News and Research

Further Reading

Researchers to begin drug development projects for rare and neglected diseases

Exercise may help fibromyalgia: Study

New human research shows benefits and challenges for aging brain

New Chair of Forensic Mental Health at the University of New South Wales

Yissum Research and other investors complete additional investment round of $3 million in Avraham Pharmaceuticals

Top-line results from Probiodrug's PQ912 Phase 1 SAD, MAD study for Alzheimer's disease

Study uses fMRI to assess changes in brain after exercise intervention

Conference highlights advances in evidence-based integrative therapies for cancer

Kessler Foundation neuropsychologists receive National Multiple Sclerosis Society grants

Researchers discover biomarker for earlier diagnosis of MS

GPS enabled shoes for “wandering seniors”

Short sleep duration linked to weight gain in teens

Common link between Type 2 diabetes and autism

Autism in low birth weight babies five times more common: Study

Accera identifies genetic profile of AD patients with heightened response to Axona

Obese post-menopausal women outperform normal weight counterparts in cognitive tasks

RAZCER (Rapid Astrazeneca and CARO Evaluation of Radio-modifiers) awards announced - five Canadians win

Shield commences two ST10 Phase 3 studies in iron deficiency anaemia

Measurable changes in brain function may be a consequence of early HIV infection

NICU stress linked with alterations in brain structure and function of preterm infants

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News